Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2% Cholesterol Cream in Mild to Moderate Atopic Dermatitis
NCT07503197Enrolling by invitation
- Sponsor
- St John's Institute of Dermatology
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in atopic dermatitis (AD) comparing Topical 2% cholesterol cream with Placebo Vehicle Cream (2 arms). Primary endpoint: Transepidermal Water Loss at 12 weeks. Started Apr 2026; status: enrolling by invitation.
02
Drugs
cholesterol cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07503197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07503197.